Literature DB >> 28989173

Diabetic nephropathy: Renoprotective effects of GLP1R agonists and SGLT2 inhibitors.

Berthold Hocher1, Oleg Tsuprykov2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28989173     DOI: 10.1038/nrneph.2017.140

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN: 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  10 in total

1.  Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.

Authors:  E J Lewis; L G Hunsicker; W R Clarke; T Berl; M A Pohl; J B Lewis; E Ritz; R C Atkins; R Rohde; I Raz
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

Review 2.  Adenosine A1 receptor antagonists in clinical research and development.

Authors:  Berthold Hocher
Journal:  Kidney Int       Date:  2010-06-30       Impact factor: 10.612

3.  The dipeptidyl peptidase inhibitor linagliptin and the angiotensin II receptor blocker telmisartan show renal benefit by different pathways in rats with 5/6 nephrectomy.

Authors:  Oleg Tsuprykov; Ryotaro Ando; Christoph Reichetzeder; Karoline von Websky; Viktoriia Antonenko; Yuliya Sharkovska; Lyubov Chaykovska; Jan Rahnenführer; Ahmed A Hasan; Harald Tammen; Markus Alter; Thomas Klein; Seiji Ueda; Sho-Ichi Yamagishi; Seiya Okuda; Berthold Hocher
Journal:  Kidney Int       Date:  2016-03-24       Impact factor: 10.612

4.  Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.

Authors:  B M Brenner; M E Cooper; D de Zeeuw; W F Keane; W E Mitch; H H Parving; G Remuzzi; S M Snapinn; Z Zhang; S Shahinfar
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

Review 5.  GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes.

Authors:  Marcel H A Muskiet; Lennart Tonneijck; Mark M Smits; Michaël J B van Baar; Mark H H Kramer; Ewout J Hoorn; Jaap A Joles; Daniël H van Raalte
Journal:  Nat Rev Nephrol       Date:  2017-09-04       Impact factor: 28.314

Review 6.  Renal, metabolic and cardiovascular considerations of SGLT2 inhibition.

Authors:  Ralph A DeFronzo; Luke Norton; Muhammad Abdul-Ghani
Journal:  Nat Rev Nephrol       Date:  2016-12-12       Impact factor: 28.314

7.  Liraglutide and Renal Outcomes in Type 2 Diabetes.

Authors:  Johannes F E Mann; David D Ørsted; Kirstine Brown-Frandsen; Steven P Marso; Neil R Poulter; Søren Rasmussen; Karen Tornøe; Bernard Zinman; John B Buse
Journal:  N Engl J Med       Date:  2017-08-31       Impact factor: 91.245

8.  Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.

Authors:  Christoph Wanner; Silvio E Inzucchi; John M Lachin; David Fitchett; Maximilian von Eynatten; Michaela Mattheus; Odd Erik Johansen; Hans J Woerle; Uli C Broedl; Bernard Zinman
Journal:  N Engl J Med       Date:  2016-06-14       Impact factor: 91.245

9.  Empagliflozin and Cerebrovascular Events in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk.

Authors:  Bernard Zinman; Silvio E Inzucchi; John M Lachin; Christoph Wanner; David Fitchett; Sven Kohler; Michaela Mattheus; Hans J Woerle; Uli C Broedl; Odd Erik Johansen; Gregory W Albers; Hans Christoph Diener
Journal:  Stroke       Date:  2017-04-06       Impact factor: 7.914

10.  Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

Authors:  Steven P Marso; Gilbert H Daniels; Kirstine Brown-Frandsen; Peter Kristensen; Johannes F E Mann; Michael A Nauck; Steven E Nissen; Stuart Pocock; Neil R Poulter; Lasse S Ravn; William M Steinberg; Mette Stockner; Bernard Zinman; Richard M Bergenstal; John B Buse
Journal:  N Engl J Med       Date:  2016-06-13       Impact factor: 176.079

  10 in total
  10 in total

1.  The cell membrane repair protein MG53 modulates transcription factor NF-κB signaling to control kidney fibrosis.

Authors:  Haichang Li; Pu Duann; Zhongguang Li; Xinyu Zhou; Jianjie Ma; Brad H Rovin; Pei-Hui Lin
Journal:  Kidney Int       Date:  2021-10-30       Impact factor: 10.612

2.  Differential and shared genetic effects on kidney function between diabetic and non-diabetic individuals.

Authors:  Thomas W Winkler; Humaira Rasheed; Alexander Teumer; Mathias Gorski; Bryce X Rowan; Kira J Stanzick; Laurent F Thomas; Adrienne Tin; Anselm Hoppmann; Audrey Y Chu; Bamidele Tayo; Chris H L Thio; Daniele Cusi; Jin-Fang Chai; Karsten B Sieber; Katrin Horn; Man Li; Markus Scholz; Massimiliano Cocca; Matthias Wuttke; Peter J van der Most; Qiong Yang; Sahar Ghasemi; Teresa Nutile; Yong Li; Giulia Pontali; Felix Günther; Abbas Dehghan; Adolfo Correa; Afshin Parsa; Agnese Feresin; Aiko P J de Vries; Alan B Zonderman; Albert V Smith; Albertine J Oldehinkel; Alessandro De Grandi; Alexander R Rosenkranz; Andre Franke; Andrej Teren; Andres Metspalu; Andrew A Hicks; Andrew P Morris; Anke Tönjes; Anna Morgan; Anna I Podgornaia; Annette Peters; Antje Körner; Anubha Mahajan; Archie Campbell; Barry I Freedman; Beatrice Spedicati; Belen Ponte; Ben Schöttker; Ben Brumpton; Bernhard Banas; Bernhard K Krämer; Bettina Jung; Bjørn Olav Åsvold; Blair H Smith; Boting Ning; Brenda W J H Penninx; Brett R Vanderwerff; Bruce M Psaty; Candace M Kammerer; Carl D Langefeld; Caroline Hayward; Cassandra N Spracklen; Cassianne Robinson-Cohen; Catharina A Hartman; Cecilia M Lindgren; Chaolong Wang; Charumathi Sabanayagam; Chew-Kiat Heng; Chiara Lanzani; Chiea-Chuen Khor; Ching-Yu Cheng; Christian Fuchsberger; Christian Gieger; Christian M Shaffer; Christina-Alexandra Schulz; Cristen J Willer; Daniel I Chasman; Daniel F Gudbjartsson; Daniela Ruggiero; Daniela Toniolo; Darina Czamara; David J Porteous; Dawn M Waterworth; Deborah Mascalzoni; Dennis O Mook-Kanamori; Dermot F Reilly; E Warwick Daw; Edith Hofer; Eric Boerwinkle; Erika Salvi; Erwin P Bottinger; E-Shyong Tai; Eulalia Catamo; Federica Rizzi; Feng Guo; Fernando Rivadeneira; Franco Guilianini; Gardar Sveinbjornsson; Georg Ehret; Gerard Waeber; Ginevra Biino; Giorgia Girotto; Giorgio Pistis; Girish N Nadkarni; Graciela E Delgado; Grant W Montgomery; Harold Snieder; Harry Campbell; Harvey D White; He Gao; Heather M Stringham; Helena Schmidt; Hengtong Li; Hermann Brenner; Hilma Holm; Holgen Kirsten; Holly Kramer; Igor Rudan; Ilja M Nolte; Ioanna Tzoulaki; Isleifur Olafsson; Jade Martins; James P Cook; James F Wilson; Jan Halbritter; Janine F Felix; Jasmin Divers; Jaspal S Kooner; Jeannette Jen-Mai Lee; Jeffrey O'Connell; Jerome I Rotter; Jianjun Liu; Jie Xu; Joachim Thiery; Johan Ärnlöv; Johanna Kuusisto; Johanna Jakobsdottir; Johanne Tremblay; John C Chambers; John B Whitfield; John M Gaziano; Jonathan Marten; Josef Coresh; Jost B Jonas; Josyf C Mychaleckyj; Kaare Christensen; Kai-Uwe Eckardt; Karen L Mohlke; Karlhans Endlich; Katalin Dittrich; Kathleen A Ryan; Kenneth M Rice; Kent D Taylor; Kevin Ho; Kjell Nikus; Koichi Matsuda; Konstantin Strauch; Kozeta Miliku; Kristian Hveem; Lars Lind; Lars Wallentin; Laura M Yerges-Armstrong; Laura M Raffield; Lawrence S Phillips; Lenore J Launer; Leo-Pekka Lyytikäinen; Leslie A Lange; Lorena Citterio; Lucija Klaric; M Arfan Ikram; Marcus Ising; Marcus E Kleber; Margherita Francescatto; Maria Pina Concas; Marina Ciullo; Mario Piratsu; Marju Orho-Melander; Markku Laakso; Markus Loeffler; Markus Perola; Martin H de Borst; Martin Gögele; Martina La Bianca; Mary Ann Lukas; Mary F Feitosa; Mary L Biggs; Mary K Wojczynski; Maryam Kavousi; Masahiro Kanai; Masato Akiyama; Masayuki Yasuda; Matthias Nauck; Melanie Waldenberger; Miao-Li Chee; Miao-Ling Chee; Michael Boehnke; Michael H Preuss; Michael Stumvoll; Michael A Province; Michele K Evans; Michelle L O'Donoghue; Michiaki Kubo; Mika Kähönen; Mika Kastarinen; Mike A Nalls; Mikko Kuokkanen; Mohsen Ghanbari; Murielle Bochud; Navya Shilpa Josyula; Nicholas G Martin; Nicholas Y Q Tan; Nicholette D Palmer; Nicola Pirastu; Nicole Schupf; Niek Verweij; Nina Hutri-Kähönen; Nina Mononen; Nisha Bansal; Olivier Devuyst; Olle Melander; Olli T Raitakari; Ozren Polasek; Paolo Manunta; Paolo Gasparini; Pashupati P Mishra; Patrick Sulem; Patrik K E Magnusson; Paul Elliott; Paul M Ridker; Pavel Hamet; Per O Svensson; Peter K Joshi; Peter Kovacs; Peter P Pramstaller; Peter Rossing; Peter Vollenweider; Pim van der Harst; Rajkumar Dorajoo; Ralene Z H Sim; Ralph Burkhardt; Ran Tao; Raymond Noordam; Reedik Mägi; Reinhold Schmidt; Renée de Mutsert; Rico Rueedi; Rob M van Dam; Robert J Carroll; Ron T Gansevoort; Ruth J F Loos; Sala Cinzia Felicita; Sanaz Sedaghat; Sandosh Padmanabhan; Sandra Freitag-Wolf; Sarah A Pendergrass; Sarah E Graham; Scott D Gordon; Shih-Jen Hwang; Shona M Kerr; Simona Vaccargiu; Snehal B Patil; Stein Hallan; Stephan J L Bakker; Su-Chi Lim; Susanne Lucae; Suzanne Vogelezang; Sven Bergmann; Tanguy Corre; Tarunveer S Ahluwalia; Terho Lehtimäki; Thibaud S Boutin; Thomas Meitinger; Tien-Yin Wong; Tobias Bergler; Ton J Rabelink; Tõnu Esko; Toomas Haller; Unnur Thorsteinsdottir; Uwe Völker; Valencia Hui Xian Foo; Veikko Salomaa; Veronique Vitart; Vilmantas Giedraitis; Vilmundur Gudnason; Vincent W V Jaddoe; Wei Huang; Weihua Zhang; Wen Bin Wei; Wieland Kiess; Winfried März; Wolfgang Koenig; Wolfgang Lieb; Xin Gao; Xueling Sim; Ya Xing Wang; Yechiel Friedlander; Yih-Chung Tham; Yoichiro Kamatani; Yukinori Okada; Yuri Milaneschi; Zhi Yu; Klaus J Stark; Kari Stefansson; Carsten A Böger; Adriana M Hung; Florian Kronenberg; Anna Köttgen; Cristian Pattaro; Iris M Heid
Journal:  Commun Biol       Date:  2022-06-13

3.  Canagliflozin reduces cisplatin uptake and activates Akt to protect against cisplatin-induced nephrotoxicity.

Authors:  Zhixia Song; Jiefu Zhu; Qingqing Wei; Guie Dong; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2020-03-09

4.  GLP-1 receptor agonist ameliorates obesity-induced chronic kidney injury via restoring renal metabolism homeostasis.

Authors:  Chengshi Wang; Ling Li; Shuyun Liu; Guangneng Liao; Lan Li; Younan Chen; Jingqiu Cheng; Yanrong Lu; Jingping Liu
Journal:  PLoS One       Date:  2018-03-28       Impact factor: 3.240

5.  Up-Titration Strategy After DPP-4 Inhibitor-Based Oral Therapy for Type 2 Diabetes: A Randomized Controlled Trial Shifting to a Single-Dose GLP-1 Enhancer Versus Adding a Variable Basal Insulin Algorithm.

Authors:  Masahiko Miyagi; Hiroshi Uchino; Naoki Kumashiro; Mariko Higa; Koki Shin; Makiko Sasamoto; Hiroji Kitazato; Motoyuki Tamaki; Munehide Matsuhisa; Takahisa Hirose
Journal:  Diabetes Ther       Date:  2018-08-18       Impact factor: 2.945

6.  Long-Term Effects of Ipragliflozin on Diabetic Nephropathy and Blood Pressure in Patients With Type 2 Diabetes: 104-Week Follow-up of an Open-Label Study.

Authors:  Daisuke Ito; Kazuyuki Inoue; Takashi Sumita; Keiko Hamaguchi; Kimie Kaneko; Morifumi Yanagisawa; Kouichi Inukai; Ikuo Inoue; Mitsuhiko Noda; Akira Shimada
Journal:  J Clin Med Res       Date:  2018-07-31

7.  The combination of a neprilysin inhibitor (sacubitril) and angiotensin-II receptor blocker (valsartan) attenuates glomerular and tubular injury in the Zucker Obese rat.

Authors:  Javad Habibi; Annayya R Aroor; Nitin A Das; Camila M Manrique-Acevedo; Megan S Johnson; Melvin R Hayden; Ravi Nistala; Charles Wiedmeyer; Bysani Chandrasekar; Vincent G DeMarco
Journal:  Cardiovasc Diabetol       Date:  2019-03-25       Impact factor: 9.951

8.  Impact of sex on diabetic nephropathy and the renal transcriptome in UNx db/db C57BLKS mice.

Authors:  Frederikke E Sembach; Lisbeth N Fink; Thea Johansen; Brandon B Boland; Thomas Secher; Sebastian T Thrane; Jens C Nielsen; Keld Fosgerau; Niels Vrang; Jacob Jelsing; Tanja X Pedersen; Mette V Østergaard
Journal:  Physiol Rep       Date:  2019-12

9.  MicroRNA-10a/b inhibit TGF-β/Smad-induced renal fibrosis by targeting TGF-β receptor 1 in diabetic kidney disease.

Authors:  Jinxiang Li; Shuling Yue; Jingwen Fang; Junling Zeng; Siqi Chen; Jianwei Tian; Sheng Nie; Xiaoting Liu; Hanying Ding
Journal:  Mol Ther Nucleic Acids       Date:  2022-04-07       Impact factor: 8.886

Review 10.  Roles of Gut Microbial Metabolites in Diabetic Kidney Disease.

Authors:  Qing Fang; Na Liu; Binjie Zheng; Fei Guo; Xiangchang Zeng; Xinyi Huang; Dongsheng Ouyang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-20       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.